: The success of Merck’s antiviral — and other COVID-19 pills in development — may depend on how quickly people start taking them
That may mean starting treatment within days after testing positive for the virus.

from MarketWatch.com - Top Stories https://ift.tt/3j0uKAe
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3j0uKAe
via IFTTT
Kommentare
Kommentar veröffentlichen